Drug intelligence / Profile preview

flurbiprofen axetil + oxycodone

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Flurbiprofen axetil + oxycodone is a combination drug used primarily for postoperative analgesia. Flurbiprofen axetil is a prodrug of flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID) that provides targeted analgesia by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis and inflammation at the site of injury. Oxycodone is a semisynthetic opioid agonist that acts mainly on the mu-opioid receptor to provide potent analgesic effects, particularly effective for visceral pain. The combination leverages the distinct mechanisms of both drugs to achieve synergistic pain relief with potentially fewer adverse effects than higher doses of either agent alone. This regimen has been shown in clinical studies to be effective and safe for patient-controlled intravenous analgesia after surgery, including lower abdominal and colorectal cancer surgeries[1][2][3].

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on flurbiprofen axetil + oxycodone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flurbiprofen axetil + oxycodone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call